• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s R&D focuses on vaccines addressing high unmet medical needs.

  • Valneva covers the full value chain from research to market.

Welcome to Valneva
A fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines.

2017_ABR_Teaser

Download 2017 Valneva Annual Business Report

October 16, 2018  

Valneva Announces Progress of Chikungunya Vaccine Candidate

Read more    

— Stock information

@valnevase




















-
— July 2, 2018
Valneva Announces Significant Progress of its Lyme Disease Vaccine Candidate

Read more 
— Financial Calendar

November 8, 2018
Nine Months Results 2018



See all dates






AKTUELLES

News in German


 
VALNEVA
LIBRARY


Images, presentations and videos

JAPANESE
ENCEPHALITIS
AND
CHOLERA



learn more
play video Company Video

– Upcoming conferences



October 29-31
World Vaccine Congress Europe, Lisbon

November 13-14
Stifel 2018 Healthcare Conference, New York

November 14-15
Jefferies 2018 Healthcare Conference, London
 
Please update your browser...